How technology is reshaping risk
Digital technology is changing industries everywhere - and the pharmaceutical sector is no exception.
The buzzword is M-health. With more than 5 billion mobiles around the world, and thousands of healthcare apps already in use, the potential is vast. Young Sohn, president and chief strategy officer at Samsung Electronics calls it a "revolution in health".
How will this affect business models in the industry? How ready is the sector for change? And what are the risks that accompany these new opportunities?